OVID
Ovid Therapeutics Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ovidrx.com
- Employees(FY) 39
- ISIN US6904691010
Performance
+3.28%
1W
-0.63%
1M
-17.97%
3M
-3.67%
6M
-2.17%
YTD
-9.22%
1Y
Profile
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, currently under preclinical stage, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV825, currently under preclinical stage, which has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, currently under preclinical stage, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Technical Analysis of OVID 2024-05-10
Overview:
In analyzing the technical indicators for OVID stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...
Recent News & Updates
- 2024-05-14 01:54
- 2024-05-13 21:10
- 2024-05-13 20:00
- 2024-05-12 19:00
- 2024-04-29 19:23
- 2024-04-28 19:18
- 2024-04-25 22:00
- 2024-04-03 20:00
- 2024-03-17 05:19
5 Oversold Biotech Stocks To Buy Right Now(Insidermonkey)
- 2024-03-07 19:00
- 2024-02-27 19:00
- 2024-02-05 19:00
- 2023-11-30 18:30
- 2023-11-08 23:00
Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why(Yahoo Finance)
- 2023-11-08 19:48
Q3 2023 Ligand Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2023-11-05 06:15
- 2023-11-02 20:00
- 2023-10-18 22:44
- 2023-10-17 20:00
- 2023-10-09 20:00
- 2023-09-29 03:16
20 Countries With Highest Rate of Epilepsy(Yahoo Finance)
- 2023-09-25 19:30
- 2023-09-19 19:30
- 2023-08-29 20:00
- 2023-08-15 09:38
- 2023-08-03 21:15
- 2023-08-03 20:00
- 2023-07-31 20:00
- 2023-07-31 09:29
- 2023-07-01 22:00
Page 1 of 4
previousnext